Akili (NASDAQ: AKLI)
$0.41
(2.1%)
$0.01
Price as of May 6, 2024, 12:12 p.m. ET
Akili Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Akili Company Info
Akili, Inc. is a digital medicine company, which engages in the development of cognitive treatments through technologies. Its leveraging technologies designed to directly target the brain establishes a new category of medicine that is validated through clinical trials like a drug or medical device, but experienced like entertainment. The company is headquartered in Boston, MA.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.